$QSTG NURX PHARMACEUTICALS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NURX PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NURX PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in NURX PHARMACEUTICALS, INC. for free.
IRS Number: 870681500
Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Trading Symbol: QSTG
Company Address: 18 TECHNOLOGY, SUITE 130 IRVINE 92618
Former name: QUEST GROUP INTERNATIONAL INC, date of change: 2002-05-23
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
NURX PHARMACEUTICALS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12 2010 | QSTG | NURX PHARMACEUTICA ... | GERSHICK STEVEN | Chief Financial Of ... | Option Exercise | A | 0.11 | 50,000 | 5,500 | 50,000 | |
| Aug 12 2010 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Chief Executive Off ... | Option Exercise | A | 0.11 | 500,000 | 55,000 | 500,000 | |
| Apr 22 2010 | QSTG | NURX PHARMACEUTICA ... | Baradaran Sharyar | Director | Buy | P | 0.00 | 2,777,778 | 0 | 2,777,778 | 0 to 2.8 M |
| Apr 22 2010 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Chief Executive Off ... | Buy | P | 0.00 | 2,777,778 | 0 | 2,777,778 | 0 to 2.8 M |
| Mar 01 2010 | QSTG | NURX PHARMACEUTICA ... | LEVINE EVAN | Director | Option Exercise | A | 0.45 | 50,000 | 22,500 | 50,000 | |
| Mar 01 2010 | QSTG | NURX PHARMACEUTICA ... | LEVINE EVAN | Director | Gift | G | 0.00 | 11,500 | 0 | 1,130,615 | 1.1 M to 1.1 M (-1.01 %) |
| Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Santa Monica Capital Partners ... | 10% Owner | Gift | G | 0.00 | 50,000 | 0 | 2,387,500 | 2.4 M to 2.4 M (-2.05 %) |
| Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Santa Monica Capital Partners ... | 10% Owner | Sell | S | 0.25 | 400,000 | 100,000 | 2,437,500 | 2.8 M to 2.4 M (-14.10 %) |
| Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Santa Monica Capital Partners ... | 10% Owner | Sell | J | 0.00 | 600,000 | 0 | 2,837,500 | 3.4 M to 2.8 M (-17.45 %) |
| Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Baradaran Sharyar | Director | Option Exercise | A | 4.00 | 768,750 | 3,075,000 | 768,750 | |
| Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Chief Executive Off ... | Option Exercise | A | 4.00 | 768,750 | 3,075,000 | 768,750 | |
| Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Chief Executive Off ... | Gift | G | 0.00 | 10,000 | 0 | 789,999 | 800 K to 790 K (-1.25 %) |
| Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | LeBel Carl | Director | Option Exercise | D | 4.00 | 50,000 | 200,000 | 0 | |
| Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | LeBel Carl | Director | Option Exercise | A | 0.45 | 50,000 | 22,500 | 50,000 | |
| Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | ROSENTHALE MARVIN E | Director | Option Exercise | D | 4.00 | 50,000 | 200,000 | 0 |